Lapillus Pharmaceutical

Lapillus Therapeutics is a biotechnology company specializing in the development of advanced topical therapies for dermatological conditions. Founded by the former leadership team of Sol-Gel Technologies, the company leverages a proprietary silica-based microencapsulation platform to optimize the delivery and stability of active pharmaceutical ingredients. Their technology is designed to enhance the efficacy and safety profiles of treatments for inflammatory skin diseases such as acne and rosacea. Lapillus is currently focused on building a pipeline of pre-clinical candidates that address significant unmet needs in the global dermatology market. The company operates as a private entity with a strong foundation in specialized topical drug formulation and commercialization strategy.